Back to top

Analyst Blog

Bristol-Myers Squibb Company (BMY - Analyst Report) recently announced that it intends to spend approximately $250 million for expanding its 89 acre manufacturing unit at Massachusetts. The site has been functional since 2009. Bristol-Myers had invested approximately $750 million for the purpose.

Bristol-Myers aims to introduce the development of biologics and clinical trial manufacturing capabilities at the site through the proposed expansion. The pharma major intends to boost its workforce at the site by approximately 350 employees as a result of the expansion.

The company plans to construct two new buildings at its Massachusetts site to support the expansion. The site, which spans across 400,000-square-foot, currently boasts of six major buildings. Following the expansion, laboratory and office space of approximately 200,000 square feet will be added to the site. Bristol-Myers intends to commence the expansion process later in the year. The work is expected to be completed in 2015.

Bristol-Myers stated in its press release that in the meanwhile it has leased laboratory space of 30,000 square feet. The company intends to keep the space until the expansion work is over.

We believe that the proposed expansion is a strategic move by Bristol-Myers which will support its pipeline development efforts. Successful development of the pipeline is the key to the company's growth following the genericization (in the US) of Bristol-Myers/Sanofi’s (SNY - Analyst Report) successful blood thinner Plavix in May 2012.

Bristol-Myers, a biopharmaceutical company, carries a Zacks Rank #3 (Hold). Stocks such as Athersys, Inc. (ATHX - Snapshot Report) and Celgene Corporation (CELG - Analyst Report) appear to be more favorably placed in the biopharma space. While Athersys carries a Zacks Rank #1 (Strong Buy), Celgene carries a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
RPC INC RES 24.91 +8.35%
LITHIA MOTO… LAD 94.59 +4.60%
DELTA AIR L… DAL 39.15 +3.90%
FLAMEL TECH… FLML 14.51 +3.50%
SOUTHWEST A… LUV 28.87 +2.92%